Echo45 Advisors’s Amgen AMGN Stock Holding History

Echo45 Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-903	Closed	-$220K	–	38
2022 Q2	$220K	Sell	903 -565	-38%	-$138K	0.21%	42
2022 Q1	$355K	Sell	1,468 -427	-23%	-$98.1K	0.28%	47
2021 Q4	$426K	Buy	+1,895	New	+$400K	0.34%	48

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Echo45 Advisors's AMGN Position: Q3 2022 in Review

Echo45 Advisors sold out of Amgen (AMGN) in Q3 2022, closing a stake of 903 shares — an estimated $220K sold.

Echo45 Advisors first reported a position in AMGN in Q4 2021 and held it in 3 quarters. The position peaked at $426K in Q4 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Echo45 Advisors reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Echo45 Advisors sold 903 Amgen shares in Q3 2022, an estimated $220K.
Echo45 Advisors first reported a position in Amgen in Q4 2021 and held it in 3 quarters.
Echo45 Advisors's Amgen position peaked at $426K in Q4 2021.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Echo45 Advisors's 13F filing for Q3 2022, filed 19 Oct 2022.